Snowden Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
5,023
+206
+4% +$10K 0.01% 1118
2026
Q1
$207K Buy
4,817
+246
+5% +$10.6K 0.01% 1208
2025
Q4
$200K Buy
+4,571
New +$189K 0.01% 1222
2023
Q1
Sell
-26,170
Closed -$420K 1161
2022
Q4
$420K Buy
26,170
+1,924
+8% +$31.4K 0.02% 783
2022
Q3
$380K Buy
24,246
+7,807
+47% +$151K 0.02% 779
2022
Q2
$342K Buy
+16,439
New +$339K 0.02% 808

Other funds holding EXEL

Snowden Capital Advisors's EXEL Position: Q2 2026 in Review

Snowden Capital Advisors increased its Exelixis (EXEL) stake by 4.3% in Q2 2026, buying an estimated $10K and bringing the position to 5,023 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #1118.

Snowden Capital Advisors first reported a position in EXEL in Q2 2022 and has held it in 6 quarters since. The position peaked at $420K in Q4 2022. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Snowden Capital Advisors held 5,023 shares of Exelixis worth $273K as of Q2 2026.
  • Snowden Capital Advisors bought 206 Exelixis shares in Q2 2026, an estimated $10K.
  • Exelixis made up 0.01% of Snowden Capital Advisors's portfolio in Q2 2026, its #1118 holding.
  • Snowden Capital Advisors first reported a position in Exelixis in Q2 2022 and has held it in 6 quarters since.
  • Snowden Capital Advisors's Exelixis position peaked at $420K in Q4 2022.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.